CN106699776A - 1,2,4-triazolothiadiazole thioether derivative and preparation method and application thereof - Google Patents
1,2,4-triazolothiadiazole thioether derivative and preparation method and application thereof Download PDFInfo
- Publication number
- CN106699776A CN106699776A CN201610606991.7A CN201610606991A CN106699776A CN 106699776 A CN106699776 A CN 106699776A CN 201610606991 A CN201610606991 A CN 201610606991A CN 106699776 A CN106699776 A CN 106699776A
- Authority
- CN
- China
- Prior art keywords
- pyridine
- triazolothiadiazole
- mercapto
- formula
- thiadiazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种1,2,4-三唑并噻二唑硫醚衍生物即1,2,4-三唑并[3,4-b][1,3,4]噻二唑硫醚衍生物及其制备方法和应用。The present invention relates to a 1,2,4-triazolothiadiazole sulfide derivative namely 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole sulfide Derivatives and their preparation methods and applications.
背景技术Background technique
如今,1,2,4-三唑,1,3,4-噻二唑和吡啶衍生物常常表现出广泛和多样的活性。一些报道表明稠杂环衍生物由于其非常有价值生物活性,所以和单杂环一样有非常重要的应用。通过向1,2,4-三唑环中引入1,3,4-噻二唑环视一个有效的方法,并具有很好的活性,例如抗癌活性、抗SIRT1活性、抗炎症活性和杀菌活性等。吡啶结合单1,2,4-三唑或1,3,4-噻二唑常常出现在文献中,但是具有生物活性的吡啶结合1,2,4-三唑并[3,4-b][1,3,4]噻二唑却很少报道。Today, 1,2,4-triazole, 1,3,4-thiadiazole and pyridine derivatives often exhibit a broad and diverse range of activities. Some reports indicate that fused heterocycle derivatives have the same important applications as monoheterocycles due to their very valuable biological activities. An effective method by introducing 1,3,4-thiadiazole ring into 1,2,4-triazole ring, and has good activities, such as anticancer activity, anti-SIRT1 activity, anti-inflammatory activity and bactericidal activity Wait. Pyridine-conjugated mono-1,2,4-triazoles or 1,3,4-thiadiazoles are often found in the literature, but the biologically active pyridine-conjugated 1,2,4-triazolo[3,4-b] [1,3,4]thiadiazoles are rarely reported.
发明内容Contents of the invention
本发明目的是提供一种1,2,4-三唑并噻二唑硫醚衍生物及其制备方法和应用,它通过在微波辅助合成下用较简便的方法合成了一系列新化合物,并这些化合物有些具有良好杀菌活性,为新农药的合成探索了方法和制备技术。The object of the present invention is to provide a kind of 1,2,4-triazolothiadiazole sulfide derivatives and its preparation method and application, it synthesizes a series of new compounds by relatively simple method under microwave-assisted synthesis, and Some of these compounds have good bactericidal activity, and explore methods and preparation techniques for the synthesis of new pesticides.
所述的一种1,2,4-三唑并噻二唑硫醚衍生物,其特征在于所述1,2,4-三唑并噻二唑硫醚衍生物为3-(4-吡啶基)-[1,2,4]-三唑并[3,4-b][1,3,4]噻二唑-6-硫醚类化合物,其结构式如式(I)所示:The 1,2,4-triazolothiadiazole sulfide derivative is characterized in that the 1,2,4-triazolothiadiazole sulfide derivative is 3-(4-pyridine base)-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazole-6-sulfide compounds, the structural formula of which is shown in formula (I):
式(I)中:R为C1~C14烷基、苄基、取代苄基、噻唑、取代噻唑、吡啶或取代吡啶,所述取代苄基的取代基为卤素、甲基或腈基,取代吡啶、取代噻唑的取代基均为卤素。In formula (I): R is C1~C14 alkyl, benzyl, substituted benzyl, thiazole, substituted thiazole, pyridine or substituted pyridine, the substituent of said substituted benzyl is halogen, methyl or nitrile, and substituted pyridine , Substituents of substituted thiazoles are all halogen.
所述的一种1,2,4-三唑并噻二唑硫醚衍生物,其特征在于R选自十一烷基、2-甲基苄基、3,4-二氯苄基、3-氯苄基、4-溴苄基、4-氯苄基、4-腈基苄基、2-氯噻唑、6-氯吡啶、2-氯苄基。The 1,2,4-triazolothiadiazole sulfide derivative is characterized in that R is selected from undecyl, 2-methylbenzyl, 3,4-dichlorobenzyl, 3 -chlorobenzyl, 4-bromobenzyl, 4-chlorobenzyl, 4-cyanobenzyl, 2-chlorothiazole, 6-chloropyridine, 2-chlorobenzyl.
所述的1,2,4-三唑并噻二唑硫醚衍生物的制备方法,其特征在于包括如下步骤:The preparation method of the 1,2,4-triazolothiadiazole sulfide derivative is characterized in that it comprises the following steps:
1)将异烟酸,硫酸和无水甲醇混合,加热回流反应,生成如式(Ⅱ)所示的异烟酸甲酯,异烟酸、硫酸和无水甲醇的物质的量之比为:1:1~2:1~2,优选为1:1.2:1.2;1) Mix isonicotinic acid, sulfuric acid and anhydrous methanol, heat and reflux reaction, generate isonicotinic acid methyl ester shown in formula (II), the ratio of the amount of isonicotinic acid, sulfuric acid and anhydrous methanol is: 1:1~2:1~2, preferably 1:1.2:1.2;
2)将步骤1)得到的异烟酸甲酯与质量浓度80%的水合肼回流反应,反应结束后,将反应液冷却到室温,过滤、用冰乙酸乙酯洗涤、干燥得到如式(Ⅲ)所示的异烟肼,异烟酸甲酯与水合肼的物质的量之比为1:2.5~4.0,优选为1:3.5;2) The isonicotinic acid methyl ester obtained in step 1) is refluxed with hydrazine hydrate with a mass concentration of 80%. After the reaction is completed, the reaction solution is cooled to room temperature, filtered, washed with glacial ethyl acetate, and dried to obtain the formula (Ⅲ ) for isoniazid, the ratio of the amount of isoniazid methyl ester to hydrazine hydrate is 1:2.5 to 4.0, preferably 1:3.5;
3)将式(Ⅲ)异烟肼(10mmol)、二硫化碳(12mmol)和氢氧化钾(12mmol)混合回流反应,反应结束后旋干溶剂得到式(Ⅳ)所示的4-吡啶二硫代酰腙的钾盐;3) Isoniazid (10mmol) of formula (Ⅲ), carbon disulfide (12mmol) and potassium hydroxide (12mmol) were mixed and refluxed, and the solvent was spin-dried after the reaction to obtain 4-pyridinedithioacid shown in formula (Ⅳ). Potassium salt of hydrazone;
4)将步骤3)得到的4-吡啶二硫代酰腙的钾盐与水合肼回流反应5小时,反应完毕后加水稀释,再用稀盐酸酸化,过滤,水洗三次,干燥得到如式(Ⅴ)所示的4-氨基-5-(吡啶-4-基)-4H-1,2,4-三唑-3- 巯基;4) The potassium salt of 4-pyridine dithioacylhydrazone obtained in step 3) was reacted with hydrazine hydrate under reflux for 5 hours, diluted with water after the reaction was completed, acidified with dilute hydrochloric acid, filtered, washed three times with water, and dried to obtain the formula (Ⅴ ) represented by 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-mercapto;
5)将步骤4)得到的4-氨基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-巯基和二硫化碳溶于有机溶剂A中,再加入2滴三乙胺,加热回流,回流搅拌过夜,反应完毕后将混合液倒入碎冰中,用稀盐酸酸化至pH值为1,析出沉淀过滤,干燥得如式(Ⅵ)所示的3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基,本发明加入的三乙胺2-5滴;5) Dissolve the 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-mercapto and carbon disulfide obtained in step 4) in organic solvent A, and then add 2 drops of three Ethylamine, heated to reflux, refluxed and stirred overnight, after the reaction was completed, the mixed solution was poured into crushed ice, acidified with dilute hydrochloric acid to a pH value of 1, precipitated and filtered, and dried to obtain 3-(pyridine -4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole-6-mercapto, 2-5 drops of triethylamine added in the present invention;
6)将步骤5)得到的3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基与RCH2Cl、有机溶剂B和无机碱B混合加入到压力瓶中用微波辅助反应,反应结束后,反应液冷却至室温,冰浴沉淀,过滤,滤液用重结晶溶剂进行重结晶,获得目标产物如式(I)所示的3-(4-吡啶基)-[1,2,4]-三唑并[3,4-b][1,3,4]噻二唑-6-硫醚类化合物,RCH2Cl中的R为苯环或取代苯环、吡啶或取代吡啶、噻唑或取代噻唑,取代基为卤素、甲基或腈基;6) Combine the 3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole-6-mercapto group obtained in step 5) with RCH 2 Cl, organic solvent B and inorganic base B are mixed and added into a pressure bottle to assist the reaction with microwaves. After the reaction, the reaction solution is cooled to room temperature, precipitated in an ice bath, filtered, and the filtrate is recrystallized with a recrystallization solvent to obtain the target product such as 3-(4-pyridyl)-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazole-6-sulfides represented by formula (I) Compound, R in RCH 2 Cl is a benzene ring or a substituted benzene ring, pyridine or a substituted pyridine, thiazole or a substituted thiazole, and the substituent is a halogen, methyl or nitrile group;
各化合物的结构式如下所示:The structural formula of each compound is as follows:
所述的1,2,4-三唑并噻二唑硫醚衍生物的制备方法,其特征在于步骤3)中的异烟肼、二硫化碳和无机碱A的物质的量之比为1:1~ 2:1~2,优选为1:1.2:1.2;所述无机碱A为碳酸钾、碳酸氢钠、氢氧化钠、氢氧化钾或氢化钠中的一种或多种混合物,优选为氢氧化钾。The preparation method of the 1,2,4-triazolothiadiazole sulfide derivative is characterized in that the ratio of the amount of isoniazid, carbon disulfide and inorganic base A in step 3) is 1:1 ~2:1~2, preferably 1:1.2:1.2; the inorganic base A is one or more mixtures of potassium carbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide or sodium hydride, preferably hydrogen Potassium oxide.
所述的1,2,4-三唑并噻二唑硫醚衍生物的制备方法,其特征在于步骤4)中的4-吡啶二硫代酰腙的钾盐与水合肼的物质的量之比为:1:1~2,优选为1:1.5;水的用量以4-吡啶二硫代酰腙的钾盐的物质的量计为1~10ml/mmol,优选为5ml/mmol,所述水合肼水溶液的用量以水合肼物质的量计。The preparation method of the described 1,2,4-triazolothiadiazole sulfide derivative is characterized in that the potassium salt of 4-pyridine dithioacylhydrazone and the amount of hydrazine hydrate in step 4) The ratio is: 1:1~2, preferably 1:1.5; the amount of water is 1~10ml/mmol, preferably 5ml/mmol, based on the amount of the potassium salt of 4-pyridine dithioacylhydrazone. The amount of the aqueous solution of hydrazine hydrate is calculated by the amount of hydrazine hydrate.
所述的1,2,4-三唑并噻二唑硫醚衍生物的制备方法,其特征在于步骤5)中的4-氨基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-巯基和二硫化碳的物质的量之比为:1:1~3,优选为1:2.4;所述有机溶剂A为甲醇、乙醇、DMF和吡啶中的一种或多种混合物,优选为吡啶,有机溶剂A的用量以4-氨基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-巯基的物质的量计为1~10ml/mmol,优选4ml/mmol。The preparation method of the 1,2,4-triazolothiadiazole sulfide derivative is characterized in that 4-amino-5-(pyridin-4-yl)-4H-1,2 in step 5) , The ratio of the amount of 4-triazole-3-mercapto to carbon disulfide is: 1:1~3, preferably 1:2.4; the organic solvent A is one or more of methanol, ethanol, DMF and pyridine A mixture, preferably pyridine, the amount of organic solvent A is 1 to 10ml based on the amount of 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-mercapto /mmol, preferably 4ml/mmol.
所述的1,2,4-三唑并噻二唑硫醚衍生物的制备方法,其特征在于步骤6)中的重结晶溶剂为石油醚、甲醇、正己烷或乙醇中的一种或多种,优选为乙醇;有机溶剂B为甲醇、乙醇、DMF和吡啶中的一种或多种混合物,优选为DMF,有机溶剂B的体积用量以3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基的物质的量计为3~9ml/mmol,优选5ml/mmol;;无机碱B为碳酸钾、碳酸氢钠、氢氧化钠、氢氧化钾或氢化钠中的一种或多种混合物,优选为氢氧化钠;3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基和RCH2Cl的物质的量之比为1:1~1.5,优选为1:1.1。The preparation method of the 1,2,4-triazolothiadiazole sulfide derivative is characterized in that the recrystallization solvent in step 6) is one or more of petroleum ether, methanol, n-hexane or ethanol Kind, preferably ethanol; Organic solvent B is one or more mixtures in methanol, ethanol, DMF and pyridine, is preferably DMF, and the volume consumption of organic solvent B is 3-(pyridin-4-yl)-[1, The amount of 2,4]triazol[3,4-b][1,3,4]thiadiazole-6-mercapto is 3-9ml/mmol, preferably 5ml/mmol; the inorganic base B is carbonic acid Potassium, sodium bicarbonate, sodium hydroxide, potassium hydroxide or a mixture of one or more of sodium hydride, preferably sodium hydroxide; 3-(pyridin-4-yl)-[1,2,4]triazole The ratio of [3,4-b][1,3,4]thiadiazole-6-mercapto to RCH 2 Cl is 1:1-1.5, preferably 1:1.1.
所述的1,2,4-三唑并噻二唑硫醚衍生物的制备方法,其特征在于步骤6)中微波辅助条件为:150W、90℃、200psi下微波照射15分钟。The preparation method of the 1,2,4-triazolothiadiazole sulfide derivative is characterized in that the microwave-assisted conditions in step 6) are: microwave irradiation at 150W, 90°C, and 200psi for 15 minutes.
所述的1,2,4-三唑并噻二唑硫醚衍生物在制备杀菌剂中的应用。The application of the 1,2,4-triazolothiadiazole sulfide derivatives in the preparation of fungicides.
所述的应用,所述杀菌剂为防治终极腐霉菌、致病疫霉菌、棒孢霉、灰霉菌和立枯丝核菌的杀菌剂,1,2,4-三唑并噻二唑硫醚衍生物在杀菌剂中的浓度为100ppm。In the application, the fungicide is a fungicide for preventing and treating Pythium ultimate, Phytophthora infestans, Corynespora, Botrytis cinerea and Rhizoctonia solani, 1,2,4-triazolothiadiazole sulfide The concentration of the derivative in the fungicide is 100ppm.
与现有技术相比,本发明的有益效果主要体现在:本发明提供了一种3-(4-吡啶基)-[1,2,4]-三唑并[3,4-b][1,3,4]噻二唑-6-硫醚衍生物及其制备方法与制备杀菌剂中的应用,本发明所述化合物在100μg/mL浓度下对终极腐霉(比如番茄猝倒病菌)表现出了较好的抑制性,抑制率高达100%,如本发明得到的化合物I-1、化合物I-3及化合物I-4制得的杀菌剂对防治终极腐霉菌有明显抑制效果,本发明所述化合物为具有杀菌活性的新化合物,为新农药的研发提供了基础。Compared with the prior art, the beneficial effects of the present invention are mainly reflected in: the present invention provides a 3-(4-pyridyl)-[1,2,4]-triazolo[3,4-b][ 1,3,4] Thiadiazole-6-sulfide derivatives and their preparation methods and applications in the preparation of fungicides, the compound of the present invention is effective against ultimate Pythium (such as tomato damping-off pathogen) at a concentration of 100 μg/mL Showed better inhibition, the inhibition rate is as high as 100%, and the fungicides obtained as the compound I-1, compound I-3 and compound I-4 obtained by the present invention have obvious inhibitory effect on the prevention and treatment of Pythium ultima. The compound described in the invention is a new compound with bactericidal activity, which provides a basis for the research and development of new pesticides.
本发明的反应方程式如下:Reaction equation of the present invention is as follows:
具体实施方式detailed description
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此:The present invention is further described below in conjunction with specific embodiment, but protection scope of the present invention is not limited thereto:
实施例1Example 1
(1)异烟酸乙酯式(Ⅱ)的合成:(1) Synthesis of ethyl isonicotinate formula (Ⅱ):
将异烟酸(0.1mol)、硫酸(0.12mol)和无水甲醇(0.12mol)加入到150ml单口烧瓶中,加热回流反应,反应结束后萃取,旋掉溶剂,水洗烘干,制得式(Ⅱ)所示异烟酸甲酯12.08g,产率80%。Add isonicotinic acid (0.1mol), sulfuric acid (0.12mol) and anhydrous methanol (0.12mol) into a 150ml single-necked flask, heat to reflux for reaction, extract after the reaction, spin off the solvent, wash and dry to obtain the formula ( Ⅱ) 12.08g of isonicotinic acid methyl ester, the yield is 80%.
(2)异烟肼式(Ⅲ)的合成:(2) Synthesis of isoniazid formula (Ⅲ):
式(Ⅱ)(1.37g,10mmol)和质量浓度80%水合肼水溶液(2mL,35mmol)加热回流6h,冷却到室温,过滤,滤饼用冰乙酸乙酯洗涤,干燥得到式(Ⅲ)所示异烟肼,产率(1.0g,73%)。Formula (II) (1.37g, 10mmol) and mass concentration 80% hydrazine hydrate aqueous solution (2mL, 35mmol) were heated to reflux for 6h, cooled to room temperature, filtered, the filter cake was washed with glacial ethyl acetate, and dried to obtain the formula (III) Isoniazid, yield (1.0 g, 73%).
(3)4-吡啶二硫代酰腙钾盐式(Ⅳ)的合成:(3) Synthesis of 4-pyridine dithioacylhydrazone potassium salt formula (Ⅳ):
式(Ⅲ)异烟肼(10mmol)、二硫化碳(12mmol)和氢氧化钾(12mmol)混合回流反应,反应结束后旋干溶剂得到式(Ⅳ)所示的4-吡啶二硫代酰腙的钾盐。Formula (Ⅲ) isoniazid (10mmol), carbon disulfide (12mmol) and potassium hydroxide (12mmol) mixed reflux reaction, spin dry solvent after reaction and obtain the potassium of 4-pyridine dithioacylhydrazone shown in formula (Ⅳ) Salt.
(4)4-氨基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-巯基式(Ⅴ)的合成:(4) Synthesis of 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-mercapto formula (Ⅴ):
将上述制得的(Ⅳ)(10mmol)和水合肼(15mmol)混合,加热回流反应5h,反应完毕后向反应液中加入50ml水,稀盐酸酸化,有沉淀析出,过滤,滤饼用水洗(10ml*3),干燥得白色固体(Ⅴ)。Mix (Ⅳ) (10mmol) and hydrazine hydrate (15mmol) prepared above, heat and reflux for 5h, add 50ml of water to the reaction solution after the reaction, acidify with dilute hydrochloric acid, precipitate, filter, and wash the filter cake with water ( 10ml*3), and dried to obtain a white solid (Ⅴ).
(5)3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基式(Ⅵ) 的合成:(5) Synthesis of 3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole-6-mercapto formula (Ⅵ):
将上述制得的(Ⅴ)(5mmol)、二硫化碳(12mmol)和几滴三乙胺加入到20ml吡啶中,加热回流,搅拌过夜。然后将混合液倒入100g碎冰中,盐酸酸化至pH=1,析出沉淀,过滤重结晶得式(Ⅵ),产率35%。Add (Ⅴ) (5 mmol) prepared above, carbon disulfide (12 mmol) and a few drops of triethylamine into 20 ml of pyridine, heat to reflux, and stir overnight. Then the mixture was poured into 100 g of crushed ice, acidified with hydrochloric acid to pH = 1, precipitated, filtered and recrystallized to obtain formula (VI), with a yield of 35%.
(6)目标化合物式(I)的合成:(6) synthesis of target compound formula (I):
将DMF(5mL),式(Ⅵ)(步骤(5)方法合成0.25g,1mmol),2-甲基氯苄(1.1mmol)和NaOH(0.05g,1.2mmol)加入CEM压力罐中,然后微波合成仪在(150W,90℃,200psi,15minutes)条件下工作,完成后微波仪通过压缩空气将其冷却至室温。而后将混合物倒入(40mL)碎冰中形成沉淀后过滤。粗产物(滤液)经乙醇重结晶,制得目标化合物式(I-1)所示6-((2-甲基氯苄)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑。产率57.8%。DMF (5mL), formula (VI) (step (5) method synthesis 0.25g, 1mmol), 2-methyl benzyl chloride (1.1mmol) and NaOH (0.05g, 1.2mmol) were added in the CEM pressure tank, then microwave The synthesizer works under the conditions of (150W, 90°C, 200psi, 15minutes), and the microwave instrument cools it to room temperature through compressed air after completion. The mixture was then poured (40 mL) into crushed ice to form a precipitate which was filtered. The crude product (filtrate) was recrystallized from ethanol to obtain 6-((2-methylbenzyl chloride) mercapto)-3-(pyridin-4-yl)-[1,2 ,4] Triazol[3,4-b][1,3,4]thiadiazole. Yield 57.8%.
(I-1) (I-1)
6-((2-甲基氯苄)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑m.p.130-133℃,Yield 57.8%,1H NMR(CDCl3,500MHz),δ:8.71(d,J=6.2Hz,2H,py-H),7.99(d,J=6.1Hz,2H,py-H),7.27-7.20(m,2H,Ar-H),7.11-7.01(m,2H,Ar-H),4.19(s,2H,SCH2-),2.43(s,3H,-CH3);ESI-MS:360[M+H]+;Elemental anal.For C16H13N5S2(%),calculated:C,56.62;H,3.86;N,20.63;found:C,56.77;H,3.98;N,20.65.6-((2-methylbenzyl chloride)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole mp130-133℃, Yield 57.8%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.71 (d, J=6.2Hz, 2H, py-H), 7.99 (d, J=6.1Hz, 2H, py- H),7.27-7.20(m,2H,Ar-H),7.11-7.01(m,2H,Ar-H),4.19(s,2H,SCH 2 -),2.43(s,3H,-CH 3 ) ; ESI-MS: 360[M+H] + ; Elemental anal. For C 16 H 13 N 5 S 2 (%), calculated: C, 56.62; H, 3.86; N, 20.63; found: C, 56.77; H ,3.98; N,20.65.
实施例2Example 2
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的CH3(CH2)10Cl,其他操作同实施例1,获得3-(吡唑-4-基)-6-(十一烷基巯基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(Ⅰ-2),产率102.3%。The 2-methylbenzyl chloride in step (6) of Example 1 was replaced by 1.1 mmol of CH 3 (CH 2 ) 10 Cl, and other operations were the same as in Example 1 to obtain 3-(pyrazol-4-yl)-6 -(Undecylmercapto)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-2), the yield is 102.3%.
(Ⅰ-2) (Ⅰ-2)
3-(吡唑-4-基)-6-(十一烷基巯基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑Whitesolid,m.p.120-122℃,yield 102.3%,1H NMR(CDCl3,500MHz),δ:8.74(d,J=6.1Hz,2H,Py-H),8.10(d,J=6.1Hz,2H,py-H),4.76(s,2H,SCH2-),1.26-1.45(m,18H,CH2),0.89(t,3H,CH3);ESI-MS:390[M+H]+;Elemental anal.For C19H27N5S2(%),calculated:C,58.58;H,6.99;N,17.98;found:C,58.65;H,7.12;N,17.88.3-(pyrazol-4-yl)-6-(undecylmercapto)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole Whitesolid,mp120 -122℃, yield 102.3%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.74(d, J=6.1Hz, 2H, Py-H), 8.10(d, J=6.1Hz, 2H, py-H ), 4.76(s, 2H, SCH 2 -), 1.26-1.45(m, 18H, CH 2 ), 0.89(t, 3H, CH 3 ); ESI-MS: 390[M+H] + ; Elemental anal. For C 19 H 27 N 5 S 2 (%), calculated: C, 58.58; H, 6.99; N, 17.98; found: C, 58.65; H, 7.12; N, 17.88.
实施例3Example 3
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的3,4-二氯氯苄,其他操作同实施例1,获得6-((3,4-二氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(Ⅰ-3),产率61.1%。The 2-methyl benzyl chloride in step (6) of Example 1 is replaced with 1.1 mmol of 3,4-dichloro benzyl, and other operations are the same as in Example 1 to obtain 6-((3,4-dichloro benzyl )mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (Ⅰ-3), yield 61.1% .
(Ⅰ-3) (Ⅰ-3)
6-((3,4-二氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑White solid,yield 61.1%,1H NMR(CDCl3,500MHz),δ:8.76(d,2H,py-H),8.06(d,2H,py-H),7.52(d,1H,Ar-H),7.40(d,1H,Ar-H), 7.29-7.28(m,1H,Ar-H),4.46(s,2H,SCH2-);ESI-MS:326[M+H]+;Elemental anal.For C15H9Cl2N5S2(%),calculated:C,45.69;H,2.30;N,17.76;found:C,45.45;H,2.28;N,17.65.6-((3,4-dichlorobenzyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiazo Oxadiazole White solid,yield 61.1%, 1 H NMR(CDCl 3 ,500MHz),δ:8.76(d,2H,py-H),8.06(d,2H,py-H),7.52(d,1H,Ar -H),7.40(d,1H,Ar-H), 7.29-7.28(m,1H,Ar-H),4.46(s,2H,SCH 2 -); ESI-MS:326[M+H] + ; Elemental anal. For C 15 H 9 Cl 2 N 5 S 2 (%), calculated: C, 45.69; H, 2.30; N, 17.76; found: C, 45.45; H, 2.28; N, 17.65.
实施例4Example 4
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的3-氯氯苄,其他操作同实施例1,获得6-((3-氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(Ⅰ-4),产率58.5%。The 2-methyl benzyl chloride in step (6) of Example 1 is replaced with 1.1 mmol of 3-chloro benzyl chloride, and other operations are the same as in Example 1 to obtain 6-((3-chlorobenzyl) mercapto)-3- (Pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-4), yield 58.5%.
(Ⅰ-4) (Ⅰ-4)
6-((3-氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑Yellow solid,yield 58.5%,1H NMR(CDCl3,500MHz),δ:8.74(d,J=5.9Hz,2H,py-H),8.05(d,J=6.0Hz,2H,py-H),7.35(s,1H,Ar-H),7.32-7.28(m,1H,Ar-H),7.25(d,J=6.3Hz,2H,Ar-H),4.42(s,2H,SCH2-);ESI-MS:326[M+H]+;Elemental anal.For C15H10ClN5S2(%),calculated:C,50.07;H,2.80;N,19.46;found:C,49.89;H,2.88;N,19.65.6-((3-chlorobenzyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole Yellow solid, yield 58.5%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.74 (d, J=5.9Hz, 2H, py-H), 8.05 (d, J=6.0Hz, 2H, py-H), 7.35(s,1H,Ar-H),7.32-7.28(m,1H,Ar-H),7.25(d,J=6.3Hz,2H,Ar-H),4.42(s,2H,SCH 2 -) ; ESI-MS: 326[M+H] + ; Elemental anal. For C 15 H 10 ClN 5 S 2 (%), calculated: C, 50.07; H, 2.80; N, 19.46; found: C, 49.89; H ,2.88; N,19.65.
实施例5Example 5
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的4-溴氯苄,其他操作同实施例1,获得6-((4-溴苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(I-5),产率79.4%。The 2-methylbenzyl chloride in the step (6) of Example 1 is replaced with 1.1 mmol of 4-bromobenzyl chloride, and other operations are the same as in Example 1 to obtain 6-((4-bromobenzyl) mercapto)-3- (Pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-5), yield 79.4%.
(I-5) (I-5)
6-((4-溴苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑Yellow solid,yield 79.4%,1H NMR(CDCl3,500MHz),δ:8.75(d,J=6.2Hz,2H,py-H),8.05(d,J=6.2Hz,2H,py-H),7.45(d,J=8.4Hz,2H,Ar-H),7.26(d,J=8.4Hz,2H,Ar-H),4.42(s,2H,SCH2-);ESI-MS:405[M+H]+;Elemental anal.For C15H10BrN5S2(%),calculated:C,44.56;H,2.49;N,17.32;found:C,44.59;H,2.23;N,17.32.6-((4-bromobenzyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole Yellow solid, yield 79.4%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.75 (d, J=6.2Hz, 2H, py-H), 8.05 (d, J=6.2Hz, 2H, py-H), 7.45(d, J=8.4Hz, 2H, Ar-H), 7.26(d, J=8.4Hz, 2H, Ar-H), 4.42(s, 2H, SCH 2 -); ESI-MS: 405[M +H] + ; Elemental anal. For C 15 H 10 BrN 5 S 2 (%), calculated: C, 44.56; H, 2.49; N, 17.32; found: C, 44.59; H, 2.23; N, 17.32.
实施例6Example 6
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的4-氯氯苄,其他操作同实施例1,获得6-((4-氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(I-6),91.9%。The 2-methyl benzyl chloride in step (6) of Example 1 is replaced with 1.1 mmol of 4-benzyl chloride, and other operations are the same as in Example 1 to obtain 6-((4-chlorobenzyl) mercapto)-3- (Pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-6), 91.9%.
(I-6) (I-6)
6-((4-氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑Yellow solid,yield 91.9%,1H NMR(CDCl3,500MHz),δ:8.76(d,2H,py-H),8.06(d,2H,py-H),7.34-7.28(m,4H,Ar-H),4.36(s,2H,SCH2-);ESI-MS:326[M+H]+;Elemental anal.ForC15H10ClN5S2(%),calculated:C,50.07;H,2.80;N,19.46;found:C, 49.99;H,2.68;N,19.31.6-((4-chlorobenzyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole Yellow solid, yield 91.9%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.76 (d, 2H, py-H), 8.06 (d, 2H, py-H), 7.34-7.28 (m, 4H, Ar- H), 4.36(s, 2H, SCH 2 -); ESI-MS: 326[M+H] + ; Elemental anal. For C 15 H 10 ClN 5 S 2 (%), calculated: C, 50.07; H, 2.80 ; N, 19.46; found: C, 49.99; H, 2.68; N, 19.31.
实施例7Example 7
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的4-苄甲腈,其他操作同实施例1,获得4-((3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基)基)苄甲腈(I-7),产率91.9%。The 2-methyl benzyl chloride in the embodiment 1 step (6) is replaced with 1.1mmol of 4-benzonitrile, and other operations are the same as in Example 1 to obtain 4-((3-(pyridin-4-yl)-[ 1,2,4]triazol[3,4-b][1,3,4]thiadiazol-6-mercapto)yl)benzonitrile (I-7), yield 91.9%.
(I-7) (I-7)
4-((3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑-6-巯基)基)苄甲腈Yellow solid,yield 91.9%,1H NMR(CDCl3,500MHz),δ:8.76(d,2H,py-H),8.06(d,2H,py-H),7.34-7.28(m,4H,Ar-H),4.36(s,2H,SCH2-);ESI-MS:351[M+H]+;Elemental anal.ForC16H10N6S2(%),calculated:C,54.84;H,2.88;N,23.98;found:C,54.87;H,2.97;N,24.11.4-((3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazol-6-mercapto)yl)benzonitrile Yellow solid, yield 91.9%, 1 H NMR (CDCl 3 , 500MHz), δ:8.76(d,2H,py-H),8.06(d,2H,py-H),7.34-7.28(m,4H,Ar -H), 4.36(s, 2H, SCH 2 -); ESI-MS: 351[M+H] + ; Elemental anal. For C 16 H 10 N 6 S 2 (%), calculated: C, 54.84; H, 2.88; N, 23.98; found: C, 54.87; H, 2.97; N, 24.11.
实施例8Example 8
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的2-氯噻唑,其他操作同实施例1,获得6-(((2-氯噻唑-5-基)甲基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(I-8),产率23%。The 2-methyl benzyl chloride in step (6) of Example 1 is replaced with 1.1 mmol of 2-chlorothiazole, and other operations are the same as in Example 1 to obtain 6-(((2-chlorothiazol-5-yl)methyl )mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-8), yield 23% .
(I-8) (I-8)
6-(((2-氯噻唑-5-基)甲基)巯基)-3-(吡啶-4-基)-[1,2,4] 三唑[3,4-b][1,3,4]噻二唑Yellow solid,m.p.160-162℃,yield 23.0%, 1H NMR(CDCl3,500MHz),δ:8.75(d,J=6.1Hz,2H,py-H),8.07(d,J=6.3Hz,2H,py-H),7.51(s,1H,thiazole-H),4.68(s,2H,SCH2-);ESI-MS:368[M+H]+;Elemental anal.For C12H7ClN6S3(%),calculated:C,39.29;H,1.92;N,22.91;found:C,39.43;H,1.88;N,22.79.6-(((2-chlorothiazol-5-yl)methyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3 ,4] Thiadiazole Yellow solid, mp160-162℃, yield 23.0%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.75 (d, J=6.1Hz, 2H, py-H), 8.07(d, J=6.3Hz, 2H, py-H), 7.51(s, 1H, thiazole-H), 4.68(s, 2H, SCH 2 -); ESI-MS: 368[M+H] + ; Elemental anal.For C 12 H 7 ClN 6 S 3 (%), calculated: C, 39.29; H, 1.92; N, 22.91; found: C, 39.43; H, 1.88; N, 22.79.
实施例9Example 9
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的6-氯吡啶,其他操作同实施例1,获得6-(((6-氯吡啶-3-基)甲基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑(I-9),产率74.4%。The 2-methyl benzyl chloride in step (6) of Example 1 is replaced with 1.1 mmol of 6-chloropyridine, and other operations are the same as in Example 1 to obtain 6-(((6-chloropyridin-3-yl)methyl )mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-9), yield 74.4% .
(I-9) (I-9)
6-(((6-氯吡啶-3-基)甲基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑Yellow solid,m.p.199-200℃,Yield 74.4%,1H NMR(CDCl3,500MHz),δ:8.76(d,J=6.0Hz,2H,Py-H),8.48(d,J=2.2Hz,1H,Py-H),8.06(d,J=6.1Hz,2H,Py-H),7.84(dd,J=8.2,2.4Hz,1H,Py-H),7.30(s,1H,Py-H),4.52(s,2H,SCH2-);ESI-MS:361[M+H]+;Elemental anal.For C14H9ClN6S2(%),calculated:C,46.60;H,2.51;N,23.29;found:C,46.75;H,2.37;N,23.42.6-(((6-chloropyridin-3-yl)methyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3 ,4] Thiadiazole Yellow solid, mp199-200℃, Yield 74.4%, 1 H NMR (CDCl 3 , 500MHz), δ: 8.76(d, J=6.0Hz, 2H, Py-H), 8.48(d, J=2.2Hz,1H,Py-H),8.06(d,J=6.1Hz,2H,Py-H),7.84(dd,J=8.2,2.4Hz,1H,Py-H),7.30(s, 1H, Py-H), 4.52(s, 2H, SCH 2 -); ESI-MS: 361[M+H] + ; Elemental anal. For C 14 H 9 ClN 6 S 2 (%), calculated: C, 46.60; H, 2.51; N, 23.29; found: C, 46.75; H, 2.37; N, 23.42.
实施例10Example 10
将实施例1步骤(6)中的2-甲基氯苄换成1.1mmol的2-氯氯苄,其他操作同实施例1,获得6-((2-氯苄基)巯基)-3-(吡啶-4-基) -[1,2,4]三唑[3,4-b][1,3,4]噻二唑(I-10),产率75.2%。The 2-methyl benzyl chloride in step (6) of Example 1 is replaced with 1.1 mmol of 2-benzyl chloride, and other operations are the same as in Example 1 to obtain 6-((2-chlorobenzyl) mercapto)-3- (Pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole (I-10), yield 75.2%.
(I-10) (I-10)
6-((2-氯苄基)巯基)-3-(吡啶-4-基)-[1,2,4]三唑[3,4-b][1,3,4]噻二唑Yellow solid,yield 75.2%.1H NMR(CDCl3,500MHz),δ:8.74(d,2H,py-H),8.01(d,2H,py-H),7.43-7.39(m,2H,Ar-H),7.24-7.18(m,2H,Ar-H),4.58(s,2H,SCH2-);ESI-MS:326[M+H]+;Elemental anal.For C15H10ClN5S2(%),calculated:C,50.07;H,2.80;N,19.46;found:C,50.21;H,2.88;N,19.33.6-((2-Chlorobenzyl)mercapto)-3-(pyridin-4-yl)-[1,2,4]triazol[3,4-b][1,3,4]thiadiazole Yellow solid, yield 75.2%. 1 H NMR (CDCl 3 , 500MHz), δ: 8.74 (d, 2H, py-H), 8.01 (d, 2H, py-H), 7.43-7.39 (m, 2H, Ar- H),7.24-7.18(m,2H,Ar-H),4.58(s,2H,SCH 2 -); ESI-MS:326[M+H] + ;Elemental anal.For C 15 H 10 ClN 5 S 2 (%), calculated: C, 50.07; H, 2.80; N, 19.46; found: C, 50.21; H, 2.88; N, 19.33.
实施例11杀菌活性测试Embodiment 11 bactericidal activity test
试验对象:极腐霉菌(Pythium ultimum)、致病疫霉菌(Phytophthorainfestans)、棒孢霉(Corynespora cassiicola)、灰霉菌(Botrytis cinerea)和立枯丝核菌(Rhizoctonia solani)。Test objects: Pythium ultimum, Phytophthorainfestans, Corynespora cassiicola, Botrytis cinerea and Rhizoctonia solani.
试验方法:采用盆栽试验法。将黄瓜或番茄种子经过50℃浸泡,催芽后播种于育苗钵中,待生长至2片真叶的幼苗,供试验。实验重复4次。接种病菌后,植物被维持在18-30℃[平均温度24℃,80%以上的相对湿度(RH)]。Test method: Pot test method is adopted. Soak cucumber or tomato seeds at 50°C, accelerate germination, and sow them in seedling pots. Seedlings that grow to 2 true leaves are used for testing. The experiment was repeated 4 times. After inoculation with the pathogen, plants were maintained at 18-30°C [average temperature 24°C, relative humidity (RH) above 80%].
药剂准备:取实施例1-10制备的(I-1)-(I-10)化合物各5mg,加0.5ml丙酮溶解后再加0.05ml 10%土温80,最后加50ml水充分溶解,获得100ppm样品药剂。因100ppm为100mg/L所以加水量=5mg*1000/100mg=50ml,因有机溶剂最终含量≤1%所以加丙酮的量=50ml*1%=0.5ml(溶解),因吐温最终含量为0.1%所以50ml水里应有吐温0.05ml,即:应加10%吐温0.05ml。Medicament preparation: take each 5 mg of (I-1)-(I-10) compounds prepared in Example 1-10, add 0.5 ml of acetone to dissolve, then add 0.05 ml of 10% soil temperature 80, and finally add 50 ml of water to fully dissolve to obtain 100ppm sample agent. Because 100ppm is 100mg/L so add water=5mg*1000/100mg=50ml, because the final content of organic solvent≤1%, so add the amount of acetone=50ml*1%=0.5ml (dissolving), because the final content of Tween is 0.1 % Therefore, there should be 0.05ml of Tween in 50ml of water, that is, 0.05ml of 10% Tween should be added.
对照药剂:中生菌素(zhongshengmycin)、烯酰吗啉(dimethomorph)、百菌清(chlorothalonil)、咯菌腈(fludioxoni)和井冈霉素(Validamycin)。Control agents: zhongshengmycin, dimethomorph, chlorothalonil, fludioxoni and Validamycin.
接种方法:Inoculation method:
采用菌悬液喷雾法接种:将试验对象的病菌经种子培养后,取种子液用蒸馏水稀释成3×107cfu/ml菌悬液,采用用喷壶喷雾接种至相应的植株。接种后18-30℃保湿培养。Bacterial suspension spraying method was used to inoculate: after culturing the pathogenic bacteria of the test object, the seed solution was diluted with distilled water to form 3×10 7 cfu/ml bacterial suspension, and sprayed with a watering can to inoculate corresponding plants. After inoculation, culture at 18-30°C with moisture.
施药方法:待接种病菌的幼苗长出两片复叶时,用喷壶将样品药剂与对照药剂均匀喷施在供试植株的茎叶上,以清水代替样品药剂作为空白对照。Application method: When the seedlings inoculated with the pathogen grow two compound leaves, use a watering can to evenly spray the sample drug and the control drug on the stems and leaves of the test plants, and replace the sample drug with water as a blank control.
待清水(空白实验)喷施植株充分发病后进行杀菌情况调查,并计算杀菌指数和防治效果。After the clean water (blank experiment) was sprayed on the plants and the plants were fully infected, the bactericidal situation was investigated, and the bactericidal index and control effect were calculated.
公式(1)中:EF:相对防治效果;CK:对照区终期平均病情指数;PT:处理区终期平均病情指数。In the formula (1): EF: relative control effect; CK: terminal average disease index in the control area; PT: terminal average disease index in the treatment area.
活性测试结果见表1Activity test results are shown in Table 1
表1 100ppm下各化合物的杀菌活性(%防效)The bactericidal activity (% control effect) of each compound under table 1 100ppm
从表1可以得出,化合物(I-1)对极腐霉菌(Pythium ultimum)有非常好的活性,100ppm浓度下抑制率达到100%,另外化合物(I-3)和(I-4)也表现出较好的活性,抑制率分别达到55.56%和66.67%。其他化合物对极腐霉菌(Pythium ultimum)都没有活性。除了(I-6)表现出微弱的活性,其他所有化合物对棒孢霉(Corynespora cassiicola)和灰霉菌(Botrytis cinerea)几乎没有活性。所有化合物对致病疫霉菌(Phytophthora infestans)和立枯丝核菌(Rhizoctonia solani)都没有活性。Can draw from table 1, compound (I-1) has very good activity to extreme rot mold (Pythium ultimum), and the inhibitory rate reaches 100% under the concentration of 100ppm, and compound (I-3) and (I-4) also They showed good activity, and the inhibition rates reached 55.56% and 66.67%, respectively. None of the other compounds were active against Pythium ultimum. Except for (I-6) which showed weak activity, all other compounds had little activity against Corynespora cassiicola and Botrytis cinerea. All compounds were inactive against Phytophthora infestans and Rhizoctonia solani.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610606991.7A CN106699776B (en) | 2016-07-28 | 2016-07-28 | A kind of 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610606991.7A CN106699776B (en) | 2016-07-28 | 2016-07-28 | A kind of 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106699776A true CN106699776A (en) | 2017-05-24 |
| CN106699776B CN106699776B (en) | 2019-04-26 |
Family
ID=58939645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610606991.7A Active CN106699776B (en) | 2016-07-28 | 2016-07-28 | A kind of 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106699776B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109897054A (en) * | 2017-12-08 | 2019-06-18 | 中国药科大学 | The preparation method and its usage of triazolothiadiazole c-Met kinase inhibitor |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101889585A (en) * | 2010-06-22 | 2010-11-24 | 哈尔滨工业大学 | 1 billion/gram anti-benzimidazole fungicide trichoderma conidia granule and preparation method |
| CN103102330A (en) * | 2012-11-29 | 2013-05-15 | 浙江工业大学 | N-4-methyl-1,2,3-thiadiazole-4-acyl-N-substituted phenylthiourea derivative as well as preparation and application thereof |
| CN105130917A (en) * | 2015-09-18 | 2015-12-09 | 浙江工业大学 | 1,2,4-triazolothio-ether derivative as well as preparation and application thereof |
| CN105439979A (en) * | 2015-11-11 | 2016-03-30 | 中国农业大学 | 1,2,3-thiadiazole-containing benzoyl hydrazone derivative as well as preparation method and application thereof |
-
2016
- 2016-07-28 CN CN201610606991.7A patent/CN106699776B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101889585A (en) * | 2010-06-22 | 2010-11-24 | 哈尔滨工业大学 | 1 billion/gram anti-benzimidazole fungicide trichoderma conidia granule and preparation method |
| CN103102330A (en) * | 2012-11-29 | 2013-05-15 | 浙江工业大学 | N-4-methyl-1,2,3-thiadiazole-4-acyl-N-substituted phenylthiourea derivative as well as preparation and application thereof |
| CN105130917A (en) * | 2015-09-18 | 2015-12-09 | 浙江工业大学 | 1,2,4-triazolothio-ether derivative as well as preparation and application thereof |
| CN105439979A (en) * | 2015-11-11 | 2016-03-30 | 中国农业大学 | 1,2,3-thiadiazole-containing benzoyl hydrazone derivative as well as preparation method and application thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109897054A (en) * | 2017-12-08 | 2019-06-18 | 中国药科大学 | The preparation method and its usage of triazolothiadiazole c-Met kinase inhibitor |
| CN109897054B (en) * | 2017-12-08 | 2021-12-10 | 中国药科大学 | Preparation method and application of triazolothiadiazole c-Met kinase inhibitor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106699776B (en) | 2019-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103288754B (en) | Aminoquinazolinone (thioketones) derivative replaced or its salt, its intermediate and agent for controlling noxious insect pests and using method thereof | |
| CN111362966B (en) | Bicyclic heterocyclic derivatives as IRAK4 inhibitors | |
| MXPA01007923A (en) | DERIVATIVES OF N2-PHENYL-AMIDINE. | |
| CN104829605A (en) | 1-substituted-5-trifluoromethyl-4-pyrazol-1,3,4-oxadiazole thioether or sulfone derivatives and application of derivatives | |
| CN105130917B (en) | A kind of 1,2,4- triazoles sulfide derivative and its preparation and application | |
| CN110054596B (en) | Substituted oxadiazole compound and application thereof | |
| CN103626748B (en) | A kind of diazoles compound containing pyridine and preparation and application thereof | |
| WO1997012863A1 (en) | α-SUBSTITUTED BENZYL HETEROCYCLIC DERIVATIVES, INTERMEDIATES FOR PRODUCING THE SAME, AND PESTICIDES CONTAINING THE SAME AS ACTIVE INGREDIENT | |
| JPH0853464A (en) | Microbicide | |
| CN113968799B (en) | Malononitrile compound and application thereof | |
| CN106699776A (en) | 1,2,4-triazolothiadiazole thioether derivative and preparation method and application thereof | |
| JP2001039954A (en) | Heterocyclic derivative | |
| CN106243101A (en) | A kind of 1,3,4 thiadiazoles sulfide derivatives and its preparation method and application | |
| CN116969929A (en) | 2-(Sulfonyl-5-(2-phenylthiazol-4-yl)-1,3,4-ox(thi)diazoles and their preparation methods and applications | |
| JPH0242070A (en) | 1, 2, 3-benzothiazole-4-carboxylic acid derivative as plant growth regulator | |
| CN118307535A (en) | A compound containing acrylonitrile structure and its application, a fungicide | |
| AU615280B2 (en) | Novel thiadiazines, process for production thereof, and insecticidal and acaricidal agents comprising the thiadiazines | |
| CN104650036B (en) | 6 substituted-phenyl quianzolinones and application thereof | |
| JP2001172217A (en) | Ethylene derivative having acaricidal activity and germicidal activity | |
| TW415830B (en) | Alkoxyimino benzyl derivatives and pesticides containing the same as active ingredient | |
| CN106212482B (en) | A kind of application of 1,3,4- thiadiazoles sulfide derivative in preparing herbicide | |
| CN104650038B (en) | 6- substituted pyridinyl quianzolinones and application thereof | |
| Ding et al. | Microwave Assisted Synthesis of New S-Substituted Derivatives of 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazole and Evaluation of their Antifungal Activity. | |
| JPH11209352A (en) | Thiosemicarbazones and pest-controlling agent | |
| CN110724136A (en) | Amide compound and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170524 Assignee: Hangzhou Guangyoujiu Enterprise Management Partnership (L.P.) Assignor: JIANG University OF TECHNOLOGY Contract record no.: X2023980033595 Denomination of invention: A 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application Granted publication date: 20190426 License type: Common License Record date: 20230316 Application publication date: 20170524 Assignee: Hangzhou baibeiyou Biotechnology Co.,Ltd. Assignor: JIANG University OF TECHNOLOGY Contract record no.: X2023980033594 Denomination of invention: A 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application Granted publication date: 20190426 License type: Common License Record date: 20230315 Application publication date: 20170524 Assignee: Hangzhou Zhiguo Enterprise Service Co.,Ltd. Assignor: JIANG University OF TECHNOLOGY Contract record no.: X2023980033596 Denomination of invention: A 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application Granted publication date: 20190426 License type: Common License Record date: 20230316 |
|
| EE01 | Entry into force of recordation of patent licensing contract | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170524 Assignee: Hubei Xinning Technology Co.,Ltd. Assignor: JIANG University OF TECHNOLOGY Contract record no.: X2023980035929 Denomination of invention: A 1,2,4-triazolothiadiazole sulfide derivative and its preparation method and application Granted publication date: 20190426 License type: Common License Record date: 20230525 |
|
| EE01 | Entry into force of recordation of patent licensing contract |